Aligos Therapeutics, Inc.
ALGS
DELAYED 1 MONTH
4 insider filings · Latest: Mar 9, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Julian A. SymonsExecutive Vice President, Chief Scientific Officer | Grant/Award | 23,310 | $7.03 | 23,310(D) | View → |
| Mar 9, 2026 | Mar 11 8:14 PM | Nikhil AnejaPrincipal Accounting Officer | Grant/Award | 9,450 | $7.03 | 9,450(D) | View → |
| Mar 9, 2026 | Mar 11 8:13 PM | Lesley Ann CalhounChief Operating Officer and Chief Financial Officer | Grant/Award | 37,485 | $7.03 | 37,485(D) | View → |
| Mar 9, 2026 | Mar 11 8:13 PM | BLATT LAWRENCEDirector, President and CEO | Grant/Award | 105,840 | $7.03 | 105,840(D) | View → |